Диссертация (1154682), страница 19
Текст из файла (страница 19)
–vol. 29(4). – p. 277-314.163-Shestakova M.V., Dedov I.I. Saharnyi diabet i hronicheskaya bolezn’pochek. M.: // Medicinskoe informacionnoe agentstvo. 2009. 482 s164-Shigeta T., Aoyama M., Bando Y.K., Monji A., Mitsui T., Takatsu M., etal. Dipeptidyl peptidase-4 modulates left ventricular dysfunction in chronic heartfailure via angiogenesis-dependent and -independent actions. // Circulation. –2012.
–vol. 126. – p. 1838 – 1851.165-Shim C.Y., Park S., Choi E.Y., Kang S.M., Cha B.S., Ha J.W., et al. Isalbuminuria an indicator of myocardial dysfunction in diabetic patients withoutovert heart disease? A study with Doppler strain and strain rate imaging. //Metabolism. –2008. –vol. 57(4). – p. 448–52.View ArticlePubMed.166-Shimizu I., Minamino T., Toko H., Okada S., Ikeda H., Yasuda N., et al.Excessive cardiac insulin signaling exacerbates systolic dysfunction induced bypressure overload in rodents. // J Clin Invest. –2010.
–vol. 120(5). – p. 1506 –1514.130167-Shiojima I., Walsh K. Regulation of cardiac growth and coronaryangiogenesis by the Akt/PKB signaling pathway. // Genes Dev. –2006. –vol.20(24). – p. 3347 – 3365.168-Shishehbor M.H., Hoogwerf B.J., Schoenhagen P., Marso S.P., Sun J.P.,Li J., Klein A.L., Thomas J.D., Garcia M.J. Relation of hemoglobin A1c to leftventricular relaxation in patients with type 1 diabetes mellitus and without overtheart disease. // Am J Cardiol. –2003.
–vol. 91(12). – p. 1514–151.169-Simone Theilade., Jan S Jensen., Peter Rossing., Magnus Thorsten Jensen.Arterial-ventricular coupling in type 1 diabetes: arterial stiffness is associatedwith impaired global longitudinal strain in type 1 diabetes patients—theThousand & 1 Study // Acta Diabetologica. –2017. –vol. 55(1). – p. 21-29.170-Spectre G, Ostenson CG, Li N, Hjemdahl P.
Postprandial plateletactivation is related to postprandial plasma insulin rather than glucose in patientswith type 2 diabetes. // Diabetes. –2012. –vol. 61(9). – p. 2380 – 2384.171-Stratton I.M., Adler A.I., Neil H.A., Matthews D.R., Manley S.E., CullCA., et al. Association of glycaemia with macrovascular and microvascularcomplications of type 2 diabetes (UKPDS 35): Prospective observational study.// BMJ.
–2000. –vol. 321(7258). – p. 405 – 412.172-Tahara N., Yamagishi S., Takeuchi M., Tahara A., Kaifu K., Ueda S., etal. Serum levels of advanced glycation end products (AGEs) are independentlycorrelated with circulating levels of dipeptidyl peptidase-4 (DPP-4) in humans.// Clin Biochem. –2013.
–vol. 46(4-5). – p. 300 – 303.173-TakayukiMiki.,SatoshiYuda.Diabeticcardiomyopathy:pathophysiology and clinical features.//Heart Failure Reviews. –2013. –vol.18(2). – p. 149–166.174-Takeda Y., Sakata Y., Mano T., Ohtani T., Tamaki S., Omori Y., et al.Diabetic retinopathy is associated with impaired left ventricular relaxation. JCard Fail. –2011.
–vol. 17. – p. 556 – 560.131175-Tenenbaum A., Fisman E.Z., Schwammenthal E., Adler Y., Benderly M.,Motro M., Shemesh J. Increased prevalence of left ventricular hypertrophy inhypertensive women with type 2 diabetes mellitus. // Cardiovasc Diabetol. –2003. –2:14.176-Teupe C., C. Rosak. Diabetic cardiomyopathy and diastolic heart failure– Difficulties with relaxation. // Diabetes Res Clin Pract. –2012. –vol. 97(2). –p. 185-94.177-Thomas H.
Marwick., Rebecca Ritchie., Jonathan E. Shaw., et al.Implications of Underlying Mechanisms for the Recognition and Managementof Diabetic Cardiomyopathy. // JACC. –2018. –vol. 71(3). – p. 339 – 51.178-Thrailkill K.M., Bunn R.C., Moreau C.S. et al. Matrix metalloproteinase-2 dysregulation in type 1 diabetes. // Diabetes Care. –2007. –vol. 30 (9). – p.2321-2326.179-Timothy J. Bradley., Cameron Slorach., Farid H. Mahmud., David B. Dunger., John Deanfield., Livia Deda., Yesmino Elia., Ronnie L.
H. Har., Wei Hui.,Rahim Moineddin., Heather N. Reich., James W. Scholey., Luc Mertens., Etienne Sochett and David Z. I. Cardiovascular Diabetology.–2016. – p. 15-31.180-Tocci G., Sciarretta S., Volpe M. Development of heart failure in recenthypertension trials. // J Hypertens. –2008. –vol. 26(7). – p. 1477–1486.181-Torffvit O., Lo ¨vestam-Adrian M., Agardh E., Agardh CD. Nephropathy,but not retinopathy, is associated with the development of heart disease in type1 diabetes: a 12-year observation study of 462 patients. // Diabet Med. –2005. –vol.22.
– p. 723–729.182-Vahtola E., Louhelainen M., Merasto S., Martonen E., Penttinen S., AahosI., Kyto ¨ V., Virtanen I, Mervaala E. Forkhead class O transcription factor 3aactivation and Sirtuin1 overexpression in the hypertrophied myocardium of thediabetic Goto-Kakizaki rat. // J Hypertens. –2008. – vol. 26(2). – p. 334–344.183-Van Heerebeek L., Hamdani N., Handoko M.L., Falcao-Pires I., MustersR.J., Kupreishvili K., Ijsselmuiden A.J., Schalkwijk C.G., Diamant M., Borbe132´ly A., van der Velden. J, Stienen G.J., Laarman G.J., Niessen H, W., Paulus W.J.Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advancedglycation end products, and myocyte resting tension.
// Circulation. –2008. –vol.117. – p. 43–51.184-Van Hoeven K.H., Factor S.M. A comparison of the pathologicalspectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. //Circulation. –1990. –vol. 82(3). – p. 848–855.185-Van Linthout S., Seeland U., Riad A., Eckhardt O., Hohl M., Dhayat N.,et al. Reduced MMP-2 activity contributes to cardiac fibrosis in experimentaldiabetic cardiomyopathy. // Basic Res Cardiol.
–2008. –vol. 103(4). – p. 319 –327.186-Vinereanu D., Nicolaides E., Tweddel A.C., Ma ¨dler C.F., Holst B.,Boden L.E., Cinteza M., Rees A.E., Fraser A,G. Subclinical left ventriculardysfunction in asymptomatic patients with type II diabetes mellitus, related toserum lipids and glycated haemoglobin. // Clin Sci.
–2003. –vol. 105. – p. 591–599.187-Yancy C.W., Jessup M., Bozkurt B., Butler J., Casey Jr D.E., DraznerM.H., et al. 2013 ACCF/AHA guideline for the management of heart failure: areport of the American College of Cardiology Foundation/American HeartAssociation Task Force on Practice Guidelines. // J Am Coll Cardiol. –2013. –vol.
62(16). – p. 47–239.188-Yarom R, Zirkin H., Sta ¨mmler G., Rose G. Human coronarymicrovessels in diabetes and ischaemia. Morphometric study of autopsy material.// J Pathol. –1992. –vol. 166(3). – p. 265-270.189-Yasuhide Mochizuki., Hidekazu Tanaka., Kensuke Matsumoto., HiroyukiSano., et all. Clinical features of subclinical left ventricular systolic dysfunctionin patients with diabetes mellitus. // Cardiovascular Diabetology. –2015. –14:37.190-Zabalgoitia M., Ismaeil M.F., Anderson L., Maklady F.A. Prevalence ofdiastolic dysfunction in normotensive, asymptomatic patients with well-133controlled type 2 diabetes mellitus.
// Am J Cardiol. –2001. –vol. 87(3). – p.320–323.191-Zhao-jun L.I., Lian-fang D.U., Xiang-hong LUO. Evaluation ofVentricular-vascular Coupling in Patients with Type 2 Diabetes Mellitus Using2-Dimensional Speckle Tracking Imaging // J Huazhong Univ Sci Technol MedSci. –2014. – vol. 34(6). – p. 929-934.192-Zhong J., Rao X., Rajagopalan S.
An emerging role of dipeptidylpeptidase 4 (DPP4) beyond glucose control: Potential implications incardiovascular disease. // Atherosclerosis. –2013. –vol. 226(2). – p. 305 – 314.193-Zieman S., Kass D. Advanced glycation endproduct crosslinking:Pathophysiologic role and therapeutic target in cardiovascular disease [Review].Congest Heart Fail. –2004. –vol.
10(3). – p. 144 – 149, quiz 150 – 151.194-Zieman S.J., Kass D.A. Advanced glycation endproduct crosslinking inthe cardiovascular system: potential therapeutic target for cardiovasculardisease. // Drugs. –2004. –vol. 64(5). – p. 459–70.View ArticlePubMed..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
